LYTIR

Insider · SEC Form 4 · 10% Owner

RTW INVESTMENTS, LP

In the 12 months to Nov 19, 2026, on the open market: bought $6.0M of OBIO. Filed 2 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

  1. OBIOBought: Orchestra BioMed Holdings, Inc. Nov 9, 2026 1,200,000 shares filed Nov 12, 2026 10,756,063 shares held indirectly after, as filed filing $6.0M

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Stakes filed (13D/13G)

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Filings made under this filer's SEC CIK in the same 12 months, newest first; the figure is the percentage the filing states. Every recent 13D and 13G

  1. STOKRTW Investments, LP filed Nov 16, 2026 Schedule 13G/A passive issuer: Stoke Therapeutics, Inc. filing 9.9%
  2. PYXSRTW Investments, LP filed Nov 16, 2026 Schedule 13G passive issuer: Pyxis Oncology, Inc. filing 9.9%
  3. IRTCRTW Investments, LP filed Nov 16, 2026 Schedule 13G/A passive issuer: iRhythm Holdings, Inc. filing 9.5%
  4. NGNERTW Investments, LP filed Nov 16, 2026 Schedule 13G/A passive issuer: Neurogene Inc. filing 9.3%
  5. ZLABRTW Investments, LP filed Nov 16, 2026 Schedule 13G/A passive issuer: Zai Lab Limited filing 9.2%
  6. REPLRTW Investments, LP filed Nov 16, 2026 Schedule 13G/A passive issuer: Replimune Group, Inc. filing 9%
  7. ERASRTW Investments, LP filed Nov 16, 2026 Schedule 13G/A passive issuer: Erasca, Inc. filing 6.4%
  8. LRMRRTW Investments, LP filed Nov 16, 2026 Schedule 13G passive issuer: Larimar Therapeutics, Inc. filing 5.6%
  9. SLDBRTW Investments, LP filed Nov 16, 2026 Schedule 13G passive issuer: SOLID BIOSCIENCES INC. filing 5.5%
  10. ORKARTW Investments, LP filed Nov 16, 2026 Schedule 13G/A passive issuer: ORUKA THERAPEUTICS, INC. filing 4.7%
  11. CADLRTW Investments, LP filed Nov 16, 2026 Schedule 13G/A passive issuer: CANDEL THERAPEUTICS, INC. filing 4.2%
  12. PTCTRTW Investments, LP filed Nov 16, 2026 Schedule 13G/A passive issuer: PTC Therapeutics, Inc. filing 1.9%
  13. MDGLRTW Investments, LP filed Nov 16, 2026 Schedule 13G/A passive issuer: Madrigal Pharmaceuticals, Inc. filing 1.4%
  14. FRNMRTW Investments, LP filed Nov 16, 2026 Schedule 13G/A passive issuer: Freenome, Inc. filing 0.7%
  15. TENXRTW Investments, LP filed Nov 16, 2026 Schedule 13G/A passive issuer: Tenax Therapeutics, Inc. filing 0%
  16. OBIORTW Investments, LP filed Nov 12, 2026 Schedule 13D/A may seek influence 13,142,394 shares issuer: ORCHESTRA BIOMED HOLDINGS, INC. filing 16.2%
  17. ALURRTW Investments, LP filed Sep 2, 2026 Schedule 13D/A may seek influence 67,441 shares issuer: ALLURION TECHNOLOGIES, INC. filing 9.9%
  18. TENXRTW Investments, LP filed Aug 14, 2026 Schedule 13G/A passive issuer: Tenax Therapeutics, Inc. filing 9.9%
  19. CGONRTW Investments, LP filed Aug 14, 2026 Schedule 13G/A passive issuer: CG Oncology, Inc. filing 9.7%
  20. KLRARTW Investments, LP filed Aug 14, 2026 Schedule 13G passive issuer: Kailera Therapeutics, Inc. filing 8.3%
  21. RARERTW Investments, LP filed Aug 14, 2026 Schedule 13G passive issuer: Ultragenyx Pharmaceutical Inc. filing 7.9%
  22. IRTCRTW Investments, LP filed Aug 14, 2026 Schedule 13G/A passive issuer: iRhythm Holdings, Inc. filing 6.6%
  23. RDNTRTW Investments, LP filed Aug 14, 2026 Schedule 13G/A passive issuer: RadNet, Inc. filing 6.2%
  24. QURERTW Investments, LP filed Aug 14, 2026 Schedule 13G passive issuer: uniQure N.V. filing 5.7%
  25. ORKARTW Investments, LP filed Aug 14, 2026 Schedule 13G passive issuer: ORUKA THERAPEUTICS, INC. filing 5.2%
  26. SYRERTW Investments, LP filed Aug 14, 2026 Schedule 13G/A passive issuer: Spyre Therapeutics, Inc. filing 4.8%
  27. ALURRTW INVESTMENTS, LP filed Jul 23, 2026 Schedule 13D/A may seek influence 67,441 shares issuer: ALLURION TECHNOLOGIES, INC. filing 9.9%

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • ALUR: other acquisition or disposition (code J), 4 entries, Jul 21, 2026
Code J
Another acquisition or disposition, described in the filing's footnotes.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.